Skip to main content

Profund Advisors LLC

SEC CIK
0001129919
Latest filing
Aug 11, 2026

The latest 13F from Profund Advisors LLC covers Q2 2026 (filed Aug 11, 2026): 1,175 long positions worth $3.64B. The top 10 holdings make up 40.9% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 12.0%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
160
Est. +$58.3M
Added
429
Est. +$383.7M
Reduced
583
Est. −$117.0M
Sold out
77
Est. −$42.4M

Top 5 holdings

Share of this quarter's portfolio value

  1. NVDANVIDIA Corp
    12.0%$436.7MHistory
  2. MUMicron Technology Inc
    4.9%$176.7MHistory
  3. AVGOBroadcom Inc.
    4.4%$161.0MHistory
  4. AAPLApple Inc.
    4.0%$146.8MHistory
  5. AMDAdvanced Micro Devices Inc
    3.6%$130.8MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. NVDANVIDIA Corp
    +$70.3MAddedHistory
  2. AVGOBroadcom Inc.
    +$26.3MAddedHistory
  3. SNDKSandisk Corp
    +$23.9MAddedHistory
  4. MUMicron Technology Inc
    +$19.9MAddedHistory
  5. AMDAdvanced Micro Devices Inc
    +$16.5MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. MUMicron Technology Inc
    +3.17 pp1.7% → 4.9%History
  2. AMDAdvanced Micro Devices Inc
    +2.13 pp1.5% → 3.6%History
  3. INTCIntel Corp
    +1.64 pp0.9% → 2.6%History
  4. AMATApplied Materials Inc
    +0.99 pp1.2% → 2.2%History
  5. LRCXLam Research Corp
    +0.89 pp1.2% → 2.1%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. HONHoneywell International Inc
    −$11.5MSold outHistory
  2. APLSApellis Pharmaceuticals, Inc.
    −$3.27MSold outHistory
  3. TRIThomson Reuters Corp
    −$2.57MSold outHistory
  4. TWSTTwist Bioscience Corp
    −$2.26MReducedHistory
  5. TGTXTG Therapeutics, Inc.
    −$2.17MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. HONHoneywell International Inc
    −0.42 pp0.4% → 0.0%History
  2. XOMExxonMobil Holdings Corp
    −0.36 pp0.8% → 0.5%History
  3. CVXChevron Corp
    −0.28 pp0.6% → 0.3%History
  4. NEMNEWMONT Corp
    −0.25 pp0.5% → 0.3%History
  5. AEMAgnico Eagle Mines Ltd
    −0.23 pp0.4% → 0.2%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$3.64B
+$913.0M (+33.5%) vs. prior quarter
Positions
1,175
+83 vs. prior quarter
Top 10 concentration
40.9%
Top 10 as share of value
Turnover
5.0%
Q2 2026, one quarter
Average holding period
19.6 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $3.64B (Q2 2026)

Q1 2021: $2.60BQ2 2021: $2.98BQ3 2021: $2.97BQ4 2021: $3.06BQ1 2022: $2.38BQ2 2022: $1.57BQ3 2022: $1.39BQ4 2022: $1.54BQ1 2023: $1.62BQ2 2023: $1.86BQ3 2023: $1.81BQ4 2023: $2.33BQ1 2024: $2.57BQ2 2024: $2.70BQ3 2024: $2.64BQ4 2024: $2.74BQ1 2025: $2.30BQ2 2025: $2.78BQ3 2025: $3.08BQ4 2025: $3.29BQ1 2026: $2.72BQ2 2026: $3.64B
Q1 2021Q2 2026
13F filings of Profund Advisors LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 11, 20261,175$3.64BNVDAMUAVGOvs. Q1 2026SEC
Q1 2026Apr 27, 20261,092$2.72BNVDAAAPLAVGOvs. Q4 2025SEC
Q4 2025Feb 6, 20261,249$3.29BNVDAAAPLAVGOvs. Q3 2025SEC
Q3 2025Nov 6, 20251,053$3.08BNVDAAVGOMSFTvs. Q2 2025SEC
Q2 2025Aug 7, 2025992$2.78BNVDAMSFTAVGOvs. Q1 2025SEC
Q1 2025May 8, 2025984$2.30BNVDAAAPLMSFTvs. Q4 2024SEC
Q4 2024Feb 14, 20251,103$2.74BNVDAAAPLMSFTvs. Q3 2024SEC
Q3 2024Nov 14, 20241,132$2.64BNVDAAAPLMSFTvs. Q2 2024SEC
Q2 2024Aug 13, 20241,074$2.70BNVDAMSFTAAPLvs. Q1 2024SEC
Q1 2024May 8, 20241,148$2.57BNVDAMSFTAAPLvs. Q4 2023SEC
Q4 2023Feb 14, 20241,127$2.33BAAPLMSFTNVDAvs. Q3 2023SEC
Q3 2023Nov 13, 2023968$1.81BAAPLMSFTNVDAvs. Q2 2023SEC
Q2 2023Aug 10, 20231,066$1.86BAAPLMSFTNVDAvs. Q1 2023SEC
Q1 2023May 12, 20231,089$1.62BAAPLMSFTNVDAvs. Q4 2022SEC
Q4 2022Feb 2, 20231,004$1.54BMSFTAAPLAMZNvs. Q3 2022SEC
Q3 2022Nov 7, 2022921$1.39BAAPLMSFTAMZNvs. Q2 2022SEC
Q2 2022Aug 1, 20221,014$1.57BAAPLMSFTAMZNvs. Q1 2022SEC
Q1 2022May 10, 20221,347$2.38BAAPLMSFTAMZNvs. Q4 2021SEC
Q4 2021Feb 8, 20221,376$3.06BAAPLMSFTAMZNvs. Q3 2021SEC
Q3 2021Nov 12, 20211,351$2.97BAAPLMSFTAMZNvs. Q2 2021SEC
Q2 2021Aug 12, 20211,421$2.98BAAPLAMZNMSFTvs. Q1 2021SEC
Q1 2021May 14, 20211,344$2.60BAAPLAMZNMSFT–SEC